{"transactions":[{"id":744602,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-09T20:15:27.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date."}],"balance_after":16000,"derivative":{"exercise_price":6.04,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001257544-26-000002","document":"form4-06092026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000125754426000002/form4-06092026_040601.xml","form_type":"4"}},{"id":1117867,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:45:10.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":0.58,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-016289","document":"form4-06092025_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000141588925016289/form4-06092025_040605.xml","form_type":"4"}},{"id":1486752,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:15:16.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.78,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-015961","document":"form4-06072024_040613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000141588924015961/form4-06072024_040613.xml","form_type":"4"}},{"id":1858772,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T13:02:30.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 8, 2023 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10384,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-23-036145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919123036145/doc4.xml","form_type":"4"}},{"id":2234168,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:18:44.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 9, 2022 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10384,"derivative":{"exercise_price":2.15,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-22-036298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919122036298/doc4.xml","form_type":"4"}},{"id":2237954,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T20:06:00.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":4805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted under the 2021 Plan and vest in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting."}],"balance_after":4805,"derivative":{"exercise_price":0.4339,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":4805},"source":{"system":"sec-edgar","filing":"0000899243-22-021761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000089924322021761/doc4.xml","form_type":"4"}},{"id":2237953,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T20:06:00.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":1922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the \"2021 Plan\") for 1,922 shares on 06/07/2022, which vests in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting."}],"balance_after":5766,"source":{"system":"sec-edgar","filing":"0000899243-22-021761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000089924322021761/doc4.xml","form_type":"4"}},{"id":2473754,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T19:03:39.000Z","date":"2021-12-12","kind":"grant","acquired":true,"shares":9610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting."}],"balance_after":9610,"derivative":{"exercise_price":4.78,"expiration_date":"2031-12-11","underlying":"Common Stock","underlying_shares":9610},"source":{"system":"sec-edgar","filing":"0000899243-21-048213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000089924321048213/doc4.xml","form_type":"4"}},{"id":2473753,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-14T19:03:39.000Z","date":"2021-12-12","kind":"grant","acquired":true,"shares":3844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the \"2021 Plan\") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date."}],"balance_after":3844,"source":{"system":"sec-edgar","filing":"0000899243-21-048213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000089924321048213/doc4.xml","form_type":"4"}},{"id":2663818,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:36:44.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":8109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."}],"balance_after":8109,"derivative":{"exercise_price":10.56,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":8109},"source":{"system":"sec-edgar","filing":"0001209191-21-041449","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919121041449/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-14"}},{"id":2670195,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T20:58:15.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":5834,"derivative":{"exercise_price":10.56,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001209191-21-040267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919121040267/doc4.xml","form_type":"4"}},{"id":3111912,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option Grant (right to buy)","published_at":"2020-06-12T20:49:03.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 11, 2020 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":5834,"derivative":{"exercise_price":11.38,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001209191-20-036318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919120036318/doc4.xml","form_type":"4"}},{"id":3489641,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-14T20:53:20.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 12, 2019 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":5834,"derivative":{"exercise_price":8.93,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001209191-19-037166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919119037166/doc4.xml","form_type":"4"}},{"id":3890847,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40054,"kind":"person","name":"PRYGOCKI MARK A SR","position":1,"cik":"0001257544","reported_name":"PRYGOCKI MARK A SR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-18T20:29:36.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":17502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the total shares subject to the option shall vest on June 14, 2019 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":17502,"derivative":{"exercise_price":15,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":17502},"source":{"system":"sec-edgar","filing":"0001209191-18-038316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919118038316/doc4.xml","form_type":"4"}}]}